Isis spin-out Oxford BioMedica raises £20m

2nd June 2014

Gene therapy specialist Oxford Biomedica has raised £20m to fund its portfolio of ophthalmology, CNS and cancer treatments.

The company was spun out by Oxford University Innovation in 1995.

For more information: www.oxfordbiomedica.co.uk

Press release sign up